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Abstract Otitis media (OM) describes an inflammatory
process within the middle ear space that is generally
associated with accumulation of fluid and that may lead to
hearing loss, learning difficulties, and delays in language
development. The pathogenesis of OM is multifactorial,
involving the adaptive and native immune system, eusta-
chian tube dysfunction, viral and bacterial load, and genetic
and environmental factors. The involvement of IgE-
mediated allergic reactions in the pathogenesis of OM has
been suggested by clinical observations of a high preva-
lence of OM among patients with allergies. Evidence from
studies involving tympanometric measurements, audiomet-
ric measurements, and otoscopic examination confirms the
role of atopy in the development and persistence of OM.
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Introduction
Otitis media (OM) describes an inflammatory process within
the middle ear space that is generally associated with
accumulation of fluid that results in decreased mobility of
the tympanic membrane and a conductive type of hearing loss.
It continues to be one of the most common health problems
seen in children. When inadequately treated or left untreated,
it may lead to sequelae and complications consisting of
retraction pockets, tympanosclerosis, adhesive otitis media,
permanent hearing loss, and impairment in development of
speech and language [1–4].
Two forms are recognized: acute otitis media (AOM)
and otitis media with effusion (OME). AOM is defined as
the presence of middle ear effusion (MEE) in conjunction
with the rapid onset of one or more signs or symptoms of
inflammation in the middle ear, such as otalgia, otorrhea,
fever, or irritability. OME is defined as MEE without signs
or symptoms of an acute infection; it may occur de novo or
as a sequel to AOM [5]. Therefore, AOM and OME
represent different stages of the OM continuum.
Advances in Epidemiology
An overview of published articles reveals considerable
variation in prevalence rates among the worldwide OM
reports, depending on the methods used and population
characteristics. It is recognized that most children have at
least one episode of MEE (includes AOM and OME) in
their life, but the lack of acute symptoms with OME makes
OM prevalence difficult to estimate. In the first year of life,
more than 50% of children will experience OME, and the
percentage increases to greater than 60% by age 2 years.
Many episodes resolve spontaneously within 3 months, but
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about 30% to 40% of children have recurrent OME, and 5%
to 10% of episodes last 1 year or longer [6–8]. Reviewing
some articles about the issue, Zielhuis et al. [9] used the
age-specific prevalence rate and came to the conclusion that
the rate has two peaks: one at about 2 years of age,
probably leading to immaturity of function of the immune
system and to anatomic and functional diversity of the
eustachian tube (ie, nearly horizontal orientation), and the
other at about 5 years of age, probably because children
attend the same classes at school, with consequent
increased susceptibility to infectious and allergic agents.
With increasing age, the prevalence rate of MEE decreased.
The reported prevalence rates of OM among primary school
children in the literature are 10.4% in a study from Turkey
including 912 children between 6 and 8 years of age [10],
6.8% in Italy (2,132 children, 5–14 years old) [11•], 9.5%
in The Netherlands (1,004 children, 5–8 years old) [12],
13.8% in Saudi Arabia (4,124 children, 1–8 years old) [13],
and 6.5% in Greece (5,121 children, 6–12 years old) [14].
Advances in Pathogenesis
The panel report from the Ninth International Research
Conference on Otitis Media suggests that the etiology of
OM is multifactorial, as many different factors are implicated
in the pathophysiology of this disease [15••]. OM is mainly
an infectious disease resulting from interplay between
microbial load (viral and bacterial) and immune response,
and it is clearly related to dysfunction of the eustachian tube.
All factors known to cause OM relate to these two core
elements: host factors such as age, genetic predisposition,
and atopy relate to the impaired immune system, whereas
environmental factors such as bottle feeding, mother’s
working, group day care attendance, and season of year
relate to microbial load [5].
For many years, physical obstruction of the eustachian
tube was thought to produce MEE because of negative
middle ear pressure and fluid transudation (ex vacuo
theory). Presently, more complex theories describe the
crucial role of the eustachian tube in maintaining a healthy
middle ear via equilibration of pressure between the middle
ear and ambient air (ventilatory function), protection
against nasopharyngeal pressure variations and ascending
secretions or pathogens (protective function), and clearance
of secretions and debris toward the nasopharynx (clearance
function) [16, 17]. Therefore, the dysfunction can be caused
by extrinsic factors, such as upper respiratory tracts
infections (URTIs), adenoid hypertrophy, chronic sinusitis,
or rhinitis, or by intrinsic factors, such as infection or
allergy, that are common diseases among primary school
children. Moreover, infants and young children are vulnerable
to OM because their eustachian tubes are short, floppy, and
horizontal, and they function poorly. If sustained, the
dysfunction might be followed by aspiration of potential
pathogens (viruses and bacteria) from the nasopharynx to the
middle ear. Streptococcus pneumoniae, Moraxella catarrha-
lis, nontypeable Haemophilus influenzae, and respiratory
syncytial virus or rhinovirus are the predominant pathogens
that cause OME. Pathogens or by-products stimulate local
resident cells, attracting immune-effector cells and provoking
the inflammatory response largely responsible for clinical
manifestations [18].
Role of Atopy
Recent guidelines from otologists, pediatricians, and aller-
gists based on clinical evidence support the role of atopy in
the development and persistence of OM [11•, 15••]. Atopy
had been defined by the European Academy of Allergy and
Clinical Immunology Nomenclature Task Force as a
personal or familial tendency to produce IgE antibodies in
response to low doses of allergens, usually proteins. It is the
genetic predisposition, transmitted as a dominant factor, to
become allergic to a definite number of specific allergens
[19]. Approximately 20% to 30% of the general population
and 10% to 15% of children are atopic [20].
In 1931, Proets [21] was the first to note a relationship
between patients with allergic rhinitis (AR) and OM, and
Koch [22] was the first to include observations of eosino-
philia in otorrhea, supporting the contention that the middle
ear takes part in allergic reactions similar to those seen in the
nose and sinuses. In 1967, Shambaugh [23] described middle
ear inflammation associated with allergic diseases as
“allergic otitis media.” He mentioned that one of the criteria
for the diagnosis was the presence of an extremely viscous
mucoid effusion containing eosinophils [23]. Recently, other
investigators have reported that the composition of the
inflammatory substrate in MEE is similar to the late-phase
allergic response seen in other areas of the respiratory tract,
such as in chronic sinusitis, AR, and asthma. Wright et al.
[24] demonstrated an increased expression of interleukin
(IL)-5 and eosinophils in the middle ear mucosa of patients
with OM. Hurst and Venge [25] reported elevated levels of
eosinophil cationic protein in MEE. Also, Nagamine et al.
[26] observed the accumulation of eosinophils and eosino-
phil cationic protein in MEE. Jang and Kim [27] found
significantly higher levels of allergic mediators such as IL-4,
IL-6, and tumor necrosis factor-α in the MEE of the allergic
individuals suffering from OM. Sobol et al. [28] also found
that atopic patients have a significantly higher percentage of
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T lymphocytes, eosinophils, mast cells, basophils, IL-4, and
IL-5 in MEE, and Hurst and Venge [25] reported that mast
cells and the mediator tryptase are present in the majority of
ears that have chronic effusion. Overall, these results support
the hypothesis that the immunopathologic mechanism
underlying the development of MEE can be largely a result
of the effects of T-helper type 2 (Th2) mediators; thus, the
inflammation within the middle ear of many patients is
allergic in nature. In contrast to atopic patients, nonatopic
patients revealed different cellular and cytokine profiles in
the MEE and nasopharynx, with a predominantly Th1-
mediated inflammatory response [29].
Allergy may be related to OM etiology through different
mechanisms. Experiments indicated that the middle ear
mucosa is capable of sustaining an allergic reaction;
however, the extent and duration of inflammation were
limited, and OME was not observed. It is now well-known
that the nose and middle ear are not independent entities,
but rather they belong to a system of contiguous organs,
including the nose, eustachian tube, palate, nasopharynx,
middle ear, and mastoid cells—the so-called rhinopharyng-
otubal unit. Basically, nasal allergic inflammation leads to
swelling and obstruction of the eustachian tube, which in
turn determines a negative pressure in the middle ear and an
improper ventilation. In this context, a transient eustachian
tube opening results in aspiration into the middle ear cavity
of nasopharyngeal secretions containing bacteria and
viruses with the obvious physiopathological consequences
[30•]. Moreover, several studies revealed the presence of
very similar cellular and cytokine profiles in adenoid tissue,
showing that adenoids also may represent a potential site of
allergic inflammation. Adenoid inflammation with concomi-
tant hypertrophy has long been recognized as the most
common cause of eustachian tube dysfunction in children
and, thus, of OM [31••, 32]. Reviewing the literature, we
found that many epidemiologic studies were conducted to
support the existence of a relationship between OM and
atopic disease. Using objective intradermal and in vitro
testing, many investigators have demonstrated a high
prevalence of OME among atopic patients: Dohlman (56%)
[33], Mao (29%) [34], Jordan (74%) [35], Solow (72%) [36],
Lecks (88%) [37], Fernandez and McGovern (55%) [38],
Whitcomb (100%) [39], Draper (53%) [40], Hall et al.
(100%) [41], McMahan et al. (93%) [42], Modrzyński et al.
(72%) [43], Hurst and Venge (100%) [25], Nsouli et al.
(78%) [44], Yeo et al. (28%) [45], Hurst et al. (81%) [46],
Sobol et al. (30%) [28], Alles et al. (94%) [47], and Martines
et al. (28.04%) [48••]. In our study, conducted in children 5
to 6 years of age, 60% of those with OME were atopic, while
40% were nonatopic. A total of 42.85% of the atopic
population was found to suffer from OME, while the
percentage with OME among nonatopic individuals was
6.29% [49••].
Advances in Audiological Diagnosis
The diagnosis of middle ear pathology, especially in
children, can be difficult. MEE is a prerequisite for AOM
and OME. Many diagnostic procedures are used to detect
MEE, including use of pneumatic otoscopy, tympanometry,
and acoustic reflectometry.
Pneumatic otoscopy is the primary diagnostic method for
OM recommended by the guidelines of the American
Academy of Otolaryngology Head and Neck Surgery
[50]. It provides detailed information about the change in
the tympanic membrane and the middle ear. The main
features in diagnostic assessment of the tympanic mem-
brane in OM were classified by Kaleida and Fireman [51]
into color, mobility, translucency, fluid appearance, and
retraction. Tympanic membrane findings that are suggestive
of OM are color other than pearly gray, opacification of
tympanic membrane, fluid level, decreased mobility, and
retracted position [51]. These findings are to be combined
with a clinical history to differentiate OME from AOM.
Acute symptoms in AOM may include earache, tugging or
rubbing of the ear, irritability, restless sleep, and fever.
Tympanometry is a simple and objective method that
assesses transmission and pressure system integrity of the
middle ear; it also measures auditory canal volume and
eustachian tube function by introducing air under pressure.
The tympanographic trace was classified according to basic
curve types described by Liden and Jerger: type A, normal
eustachian tube function; type B, flat tympanogram charac-
teristic of the presence of fluid in middle ear; and type C,
characterized by peaks at very negative pressures (typically
−150 decaPascal [daPa]) and may be indicative of eardrum
reaction.
Audiometry can be used to confirm the diagnosis of OM.
Conductive hearing loss is a common sequelae of OM due
to the attenuation of sound reaching the inner ear by MEE.
Audiometric threshold is considered as the pure tone
average for the frequencies 0.5 to 1 to 2 to 4 to 8 kHz
and divided as follows: normal hearing (<20 dB), light
hearing loss (21–40 dB), moderate hearing loss (41–70 dB),
severe hearing loss (71–90 dB), and profound hearing loss
(>90 dB). The report of the Eighth Research Conference of
Otitis Media stated that children with bilateral MEE had
hearing levels 10 to 16 dB worse than those of children
without MEE in all age groups. Hearing levels in children
with OM usually range from 10 to 40 dB, depending on
character and quantity of effusion [52]. Fria et al. [53]
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reported an average air conduction threshold of 27 dB in
540 children 2 to 12 years old with OME, while Ungkanont
et al. [54•] reported 31.7 dB.
Audiological Findings in Atopic Children
As stated previously, data in the literature support the
hypothesis that allergic inflammation may have a role in the
genesis and recurrence of OM. Certainly, atopy is recog-
nized as a risk factor; therefore, many epidemiologic
studies were performed to assess whether audiological
measurements in atopic individuals suffering from OM are
significantly different compared with those of nonatopic
individuals (Table 1).
Tympanometric Measurements
In 2005, considering the impact of chronic middle ear disease
regardless of age, Lazo-Saenz et al. [55] conducted a study to
assess eustachian tube function using tympanometry in
individuals with AR and to compare them with healthy
individuals with the aim of exploring the magnitude of OM
diseases in an at-risk population such as those with allergies.
The tympanometric measurements indicated that children
and adults with AR had more negative values of tympano-
metric peak pressure (TPP) than controls (P≤0.05), but the
main finding of tympanometry resulted among the children
with AR who were younger than 11 years of age. In fact, it
was shown that negative values of TPP and abnormal curves
were present in 15.5% of children (13% C curves, 3% B
curves), while only A curves were found in the control group
(P=0.03) [55]. Also, Yeo et al. [45] investigated the role of
atopy in the development of OME and its effect on
eustachian tube function after nasal provocation tests by
tympanometric measurements. A total of 142 children,
ranging in age from 9 months to 12 years, treated in the
department of ear, nose, and throat from September 2004 to
February 2006, with no history of OME or ear symptoms,
were divided into an AR group and a control group (n=63
and 79 participants, respectively). The AR group consisted
of children who had symptoms such as sneezing, watery
rhinorrhea, nasal obstruction, and pale or watery nasal
mucosae as detected by physical examination, and a positive
reaction to house dust, Dermatophagoides farinae, or
cockroach mix in allergy skin reaction tests. Of the 63
patients in the AR group in whom the authors performed
nasal provocation tests, 6.3% were found to be type B or C
by tympanometry, compared with 3.8% in the control group
[45].
Three years earlier, another study in humans tried to
establish a retrospective causal linkage by studying patients
with chronic OM to determine the history of allergic
background. In this study, Sente et al. [56] concluded that
25% of participants overall (200 patients aged 5–19 years),
80% of whom ranged in age from 5 to 9 years, with
diagnosed eustachian tube dysfunction also suffered from
AR. Moreover, the tympanometric results showed a
significant difference between B and C curves (86.5% and
13.5%, respectively, for B and C type) [56].
Leo et al. [57] recently evaluated the prevalence of
middle ear dysfunction, as assessed by tympanometry, in
children 1 to 14 years of age with chronic sinusitis among a
large group of patients with chronic respiratory symptoms,
and its possible relationship with respiratory allergy. From a
population of 1,810 children, 288 (15.9%) had a clinical
diagnosis of chronic sinusitis; of these, altered pressure of
the middle ear was found in 76.4%, with a significantly
higher prevalence among the younger children (P<0.001).
This seems to confirm that URTI is one of the predisposing
factors to OM development; moreover, the authors showed
that a positive reaction to skin prick test was found in 86
children (29.9%), with a prevalence of positivity signifi-
cantly different among various age groups (P=0.01). In
particular, the percentage values, 31.8% for children aged 3
to 6 years and 34.1% for those older than 6 years of age,
were higher than those of the healthy population (10%–
15%). Among atopic individuals, 26.7% were type C
tympanogram, while 43% were type B. Altered tympano-
gram was observed in 100% of atopic children younger
than 3 years of age, in 74.3% aged 3 to 6 years, and in
46.7% older than 6 years of age. The results demonstrate
that eustachian tube dysfunction is very common in
children with chronic sinusitis, but the dysfunction signifi-
cantly decreases in frequency with age, showing a rate of
87.5% in children younger than 3 years of age, of 79.6% in
those 3 to 6 years of age, and in 54.5% of those older than
6 years of age. The anatomic development of the upper airway
associated with higher prevalence of atopy in younger
children probably explains this change [57]. Confirmation of
these recent findings in a clinical research setting has been
poor, even though a study conducted by Ulualp et al. [58]
among patients 4 to 11 years of age with combined chronic
OME and elevated numbers of adenoid mast cells using
tympanometry showed a flat pattern with no apparent change
in compliance of all diseased ears, although it was within
normal limits in patients with isolated chronic adenoiditis
with no appearance of atopy. Our previous study, conducted
in children suffering from OME aged 5 to 6 years with the
aim of evaluating the role of atopy in children attending
primary school in Western Sicily and focusing on the
audiological characteristics among atopic and nonatopic
individuals suffering from OME, showed a statistically
significant predominance of B tympanograms in atopic
children (79.1%) compared with nonatopic children (56%)
and with an OME population (70.59%). The study of
516 Curr Allergy Asthma Rep (2011) 11:513–520
tympanometric measurements has revealed significant
differences among the considered groups (P<0.05). Ear canal
volume resulted in all cases being within normal range (0.4–
1.0 mL), but lower values were seen in atopic children (mean
value, 0.64±0.38 mL) with respect to nonatopic individuals
and to the total OME population (0.66±0.37 mL for
nonatopic individuals and 0.65±0.38 mL for the OME
population). The evaluation of TTP and of static compliance
Table 1 Published studies reporting audiological measurements in children with otitis media and atopy
Study Year Study design Samplea Outcome
Ulualp
et al. [58]
1999 Role of adenoid
mast cells in the
pathogenesis of
OME
Istanbul, Turkey;
40 children aged
4–11 y
Tympanic membrane opaque and mildly retracted in
100% of children with elevated number of adenoid
mast cells; flat pattern in 100% of tympanometry; pure
tone audiometry abnormal in 100% with a significant
difference between the children with adenoid mast cell
count below mean and patients with adenoid mast cell
count above mean (P<0.05)
Sente
et al. [56]
2001 Incidence of allergic
rhinitis in cases of
eustachian tube
dysfunction
Subotica, Croatia;
200 individuals aged
5–19 y (80% ranged
in age from 5–9 y)
26% of individuals with eustachian tube dysfunction
suffered from allergic rhinitis; 86.5% type B
tympanogram; 13.5% C curve
Modrzyński
et al. [43]
2003 Results of
tympanometry in
children with adenoid
hypertrophy and
coexisting allergy
Grudziadz, Poland;
89 children aged
4–10 y
40.5% of children with secretory otitis had positive skin
tests; 72% of atopic children presented with type B
tympanogram (19% type C); 21% of nonatopic children
presented with type B tympanogram (70% type C)
Lazo-Sàenz
et al. [55]
2005 Evaluation of eustachian
tube dysfunction in
allergic rhinitis
by tympanometry
Torreòn, Mexico; 57
children; mean age,
8.8±4.2 y for
allergic patients and
7.11±4.0 y for controls
Abnormal curves in 15.5% of cases (13% C curves, 3% B
curves); normal curves in 100% of controls (P=0.03);
mean value for tympanometric peak pressure: cases,
−54±66.2 daPa; controls, −6.17±9.44 daPa, with
significant tympanometric abnormalities among the
groups (P<0.05)
Yeo
et al. [45]
2007 Role of allergic rhinitis
in the development
of OME
Seoul, South Korea;
264 children aged
0.9–15 y
6.3% of atopic individuals (4 of 63 cases) had abnormal
tympanometric curves, compared with 3.8% of controls
(3 of 79 controls)
Leo
et al. [57]
2008 Tympanometric alterations
in children with chronic
sinusitis and positive or
negative skin tests
Milan, Italy; 288
children aged
1.9–14 y
76.4% (220 of 288) of children with chronic sinusitis presented
with altered pressure of middle ear, with a higher prevalence
among younger children (P<0.001); skin prick test positive
in 29.9% of these (P=0.01); altered tympanogram in 100%
of atopic individuals aged <3 y, in 74.3% aged 3–6 y, and in
46.7% aged >6 y
Martines
et al. [59••]
2010 Role of atopy in OME Western Sicily, Italy;
310 children aged
5–6 y
OME prevalence rate, 42.85% for atopic individuals and
6.3% for nonatopic individuals (P<0.001); OME bilateral in
79.2% of atopic and 56.3% of nonatopic individuals; B
tympanogram in 70.6%, 79.1% for atopic and 56% for
nonatopic individuals (P=0.04); mean air conduction pure
tone of 31.97 dB for atopic and 29.8 dB for nonatopic
individuals (r=0.99; P<0.001)
Martines
et al. [48••]
2011 Statistical study of
audiological findings
in OME children with
or without atopy
Western Sicily, Italy;
123 children aged
5–6 y
ANOVA test for ear canal volume (P<0.05): OME population
0.65±0.38 mL, 0.59±0.37 mL for B tympanogram,
0.79±0.36 mL for C tympanogram; atopic individuals,
0.64±0.38 mL, 0.6±0.38 mL for B tympanogram,
0.78±0.37 mL for C tympanogram; nonatopic individuals,
0.66±0.37 mL, 0.56±0.35 mL for B tympanogram,
0.80±0.37 mL for C tympanogram; ANOVA test for
tympanometric peak pressure (P<0.05): OME population,
−251.75±112.24 daPa; atopic individuals, −312.11±85.49
daPa; nonatopic individuals, −202.36±110.12; ANOVA test
for static compliance (P<0.05): OME population,
0.59±0.23 mL; atopic individuals, 0.51±0.12 mL;
nonatopic individuals, 0.65±0.28 mL
aAll studies listed were case-control studies
ANOVA analysis of variance; daPA decaPascal; OME otitis media with effusion
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(SC) among the OME population with C tympanogram also
demonstrated that lower average values of TTP and SC were
found in atopic children (P<0.05). In particular, among the
atopic population, the TTP average result was −312.11±85.49
daPa and the SC mean value was 0.51±0.12 mL, while for
nonatopic OME sufferers, the TTP average was −202.36±
110.12, and the SC mean value was 0.65±0.28 mL [59••].
Audiometric Measurements
As stated above, conductive hearing loss in OM results
from the attenuation of sound reaching the inner ear,
usually consisting of 20 to 30 dB, even if the degree of
loss varies depending on character and quantity of effusion
[60]. Ulualp et al. [58] conducted a study in children 4 to
11 years of age who suffered from chronic adenoiditis, with
the aim of evaluating the possible relationship between
atopy-adenoid mast cells and OME and/or hearing loss. The
patients were divided into two groups—OME-A (chronic
OME and chronic adenoiditis) and isolated chronic adenoi-
ditis—and underwent pure tone audiometry and adenoidec-
tomy. In addition, adenoid mast cells were counted in each
specimen. By comparing the adenoid mast cells of the two
groups, the number of adenoid mast cells in the OME-A
group (median, 80) was found to be significantly greater
than that in the isolated chronic adenoiditis group (median,
38; P<0.05), confirming the contribution of atopy to the
pathogenesis of OME. By comparing the hearing thresholds
of the groups, it was shown that all isolated chronic
adenoiditis patients had a normal hearing threshold, while
those in the OME-A group had hearing thresholds ranging
from 12 to 52 dB. Moreover, the possible relationship of
adenoid mast cells to hearing thresholds in OME-A patients
was evaluated by comparing the hearing thresholds of
OME-A patients with a mast cell count above the mean of
OME-A group, and hearing thresholds of OME-A patients
with a mast cell count below the mean of OME-A group.
The authors found that OME-A patients with an adenoid
mast cell count above the mean of the OME-A group had
significantly higher hearing thresholds compared with
OME-A patients with a mast cell count below the mean
of OME-A group (33±2 dB and 24±2 dB, respectively; P<
0.05), with a correlation coefficient r of 0.44 (P=0.004) [58].
In our report, the mean air conduction pure tone was
29.8 dB for nonatopic individuals and 31.97 dB for atopic
children, with an index correlation r of 0.99 (P<0.0001). In
both groups, hearing sensitivity ranged from slight hearing
loss (20–40 dB) to moderate hearing loss (40–70 dB), but
75% of cases with moderate hearing loss were atopic (three
of four children). The correlation between atopy and a
hearing dysfunction resulted de facto from the evidence that
the worst hearing threshold level of 55 dB, extremely rare in
individuals with OME, was found in a patient with positive
skin test; finally, there was evidence of a statistically
significant difference in predominance of bilateral OME in
atopic individuals (79.2%) compared with nonatopic indi-
viduals (56.3%) and with the total OME population (70%).
From the regression analysis, in fact, it was found that the
relative risk for bilateral OME increases significantly in the
presence of atopy (r=0.99; P=0.005) [59••].
Otoscopic Examination
Data in the literature are lacking with regard to otoscopic
findings for both the general population and for atopic
children suffering from OM. Otoscopic examination of
patients with combined chronic OME and an elevated
number of adenoid mast cells, as mentioned by Ulualp et al.
[58], revealed that 97.5% of tympanic membranes were
opaque and mildly retracted, while patients with isolated
chronic adenoiditis have gray, translucent, and mobile
tympanic membranes. From these observations, the ques-
tion naturally arises of whether the otoscopic findings and
the OM sequelae in atopic individuals are different from
those among the general OM population?
Since Li et al. [61] found that repeated OM represents
one of the clinical predictors of tympanic membrane
retraction, as in atopic children, perennial allergic inflam-
mation causes persistent blockage and dysfunction of the
eustachian tube and thus repeated inflammations of the
middle ear, it may be assumed that atopic children suffering
from OM should present with a greater prevalence of
persistent retraction than nonatopic OM sufferers. Also, for
the tympanosclerosis, intended as OM sequelae, it may be
possible to make some observations; in fact, to illuminate
the correlation of inflammatory mediators in OM and
tympanosclerosis development, Flodin and Hultcrantz [62]
investigated the inflammatory parameters in an animal
model after inoculation of S. pneumoniae into the middle
ear, as well as in children suffering from secretory OM and
in patients with already established tympanosclerosis.
Results showed the presence of macrophages, T cells, and
B cells, and increased expression of IL-6 in rats after AOM
induction, as well as in human biopsies. In particular, IL-6
expression was shown in a higher percentage of biopsies of
children suffering from OM during its active phase [62]. As
it is universally accepted, IL-6 represents one of the
principal allergic mediators, and, consequently, it is an
atopic component of OM and could induce in time to a
clinical stage known as tympanosclerosis
Conclusions
Data in the literature data seem to support the hypothesis that
allergic inflammation plays a role indirectly in the genesis and
518 Curr Allergy Asthma Rep (2011) 11:513–520
recurrence of OM by causing a persistent blockage of the
eustachian tube or directly by means of middle ear mucosa
inflammation. Several studies have shown a predominance of
eosinophils, T lymphocytes, and Th2 mediators in the MEE,
providing evidence that the inflammation within the middle
ear of OM patients is allergic in nature. Moreover, in recent
years, there has been increasing interest in the role played by
the adenoids. Studies have suggested that adenoids may
represent a potential site of allergic inflammation that can have
an effect on eustachian tube function through the release of
chemical mediators and concomitant hypertrophy, providing a
further link between allergy and middle ear disease. The role
of atopy in the development and persistence of OM is
supported by different audiological characteristics between
atopic and nonatopic individuals. Several studies have shown
that the entity of OM seems to be different from OM caused
by tubal dysfunction secondary to allergic inflammation. In
fact, data have shown significant differences in active tubal
function, in hearing acuity, and in the frequency of tympanic
membrane changes, with a predominance of altered tympano-
grams and greater hearing loss in atopic children as compared
with nonatopic children. However, very few studies have dealt
with otoscopic examination in atopic individuals, so further
studies are needed in this area.
Disclosure No potential conflicts of interest relevant to this article
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